Multibagger Shares

About Manish Goel

SEBI Registered Investment Adviser • Chartered Accountant

423 Articles Published

Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.

May 21, 2026

Hero section with the title 'Chuck Akre’s Three-Legged Stool' and subtitle 'The 25-Year Compounder Framework' on a dark blue background, featuring green accent lines and a 2x2 color grid labeled: Trader (gray), Compounder (green), Drift (light gray), Speculator (orange).

Chuck Akre’s Three-Legged Stool: The 25-Year Compounder Framework

Chuck Akre's three-legged stool — extraordinary business, exceptional management, glorious reinvestment runway — distils the compounder-picking framework. Titan Biotech's FY25 audited numbers map cleanly onto all three legs.

May 20, 2026

Hero header with dark blue gradient, large serif title 'The Outsiders Doctrine' and green italic subtitle, plus a centered multi-color donut chart labeled 'FY25 Reinvented' near the middle/bottom.

The Outsiders Doctrine: William Thorndike’s 2012 Study of Eight Unconventional CEOs and the Five Capital-Allocation Choices That Built ~20% Annual Shareholder Returns

William Thorndike's 2012 study of eight outsider CEOs revealed that compounding shareholder wealth is a capital-allocation discipline — not an operating one. Titan Biotech's FY25 audited numbers fit the five-choice template.

May 19, 2026

Infographic: The Conjunction Fallacy with a 2x2 grid—top-left 'Lucky', top-right 'DISCIPLINED INVESTOR', bottom-left 'Confused', bottom-right 'BIAS-TRAPPED'.

The Conjunction Fallacy: Tversky & Kahneman’s 1983 ‘Linda Problem’ — Why Indian Investors Believe Elaborate Multi-Leg Bull Theses Are More Probable Than Simple Ones

Tversky & Kahneman's 1983 conjunction fallacy explains why Indian retail investors judge five-leg bull stories as more probable than one-leg theses — and how single-leg corporate behaviour like Titan Biotech Ltd's audited FY25 numbers illustrates the opposite discipline.

May 19, 2026

Infographic titled 'James Montier’s Modified C-Score' with a horizontal bar chart of FY20–FY25, highlighting FY25 in green. The chart shows stacked values ending values like 3.2, 2.8, 2.1, 1.6, 1.3, and 1.1.

James Montier’s Modified C-Score: The 6-Variable Cooking-the-Books Detector That Complements Beneish M-Score and Piotroski F-Score

James Montier's Modified C-Score is a six-variable forensic detector for accounting manipulation. We decode all six variables, contrast a disciplined manufacturer with a generic red-flag profile, and show how Titan Biotech FY25's audited numbers score 0/6 — an educational illustration only, not a buy/sell recommendation.